ArticleArchives of rheumatology2023

Comparison of the efficacy and safety of oligomeric proanthocyanidins and nifedipine in patients with primary Raynaud's phenomenon: An open-label, randomized, prospective pilot study.

Kyung-Ann Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.